Condition: Lipoprotein(a) · Sponsor: Merck Sharp & Dohme LLC
Researchers designed a trial medicine called MK-7262 to lower levels of Lp(a) in the blood. Researchers want to learn about giving MK-7262 with another trial medicine called enlicitide (also known as MK-0616 or enlicitide decanoate). Enlicitide is in a group of medicines that lower the amount of low-density lipoprotein cholesterol (LDL-C). The goals of this trial are to evaluate: * if MK-7262 and enlicitide taken together work better than placebo at lowering Lp(a) and LDL-C levels in the blood * if MK-7262 alone works better than placebo at lowering Lp(a) levels in the blood * the safety and tolerability of taking MK-7262 and enlicitide alone and together
This description comes directly from the study's public registry record.
Toll Free Number · 1-888-577-8839 · Trialsites@merck.com
Always discuss trial participation with your own doctor first.
| Advanced Cardiovascular - Alexander City ( Site 0158) | Alexander City, Alabama, United States | Recruiting |
| AMR Clinical Mobile ( Site 0149) | Mobile, Alabama, United States | Recruiting |
| National Heart Institute ( Site 0113) | Beverly Hills, California, United States | Recruiting |
| Clinical Trials Research ( Site 0127) | Lincoln, California, United States | Recruiting |
| Chase Medical Research, LLC ( Site 0163) | Waterbury, Connecticut, United States | Recruiting |
| Inpatient Research Clinic ( Site 0110) | Miami Lakes, Florida, United States | Recruiting |
| Clinical Research Trials of Florida ( Site 0101) | Tampa, Florida, United States | Recruiting |
| Conquest Research LLC ( Site 0140) | Winter Park, Florida, United States | Recruiting |
| New Mexico Clinical Research & Osteoporosis Center ( Site 0119) | Albuquerque, New Mexico, United States | Recruiting |
| Remington-Davis, Inc. ( Site 0107) | Columbus, Ohio, United States | Recruiting |
| Holston Medical Group ( Site 0117) | Kingsport, Tennessee, United States | Recruiting |
| Carient Heart & Vascular - Manassas ( Site 0165) | Manassas, Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07614984